About Kritika Sarmah

Her interest in risky instruments and passion for writing made Kritika an analyst and financial journalist. She earned her bachelor's degree in commerce and is currently pursuing the CFA program. With her fundamental approach, she aims to help investors identify untapped investment opportunities.


Recent Articles By Kritika Sarmah

: KO |  News, Ratings, and Charts

1 Stock You Can Keep in Your Portfolio Forever

While consumer sentiments have been improving, there remains a possibility of longer rate hikes, which can potentially trigger a recession. However, beverage giant Coca-Cola (KO) is expected to generate steady returns considering its robust fundamentals. Moreover, the company has a long history of stable dividend payments. Hence, it could be an ideal buy for the long term. Keep reading...
: NOK |  News, Ratings, and Charts

1 Tech Stock to Buy Now for Under $5

Network solution company Nokia (NOK) reported solid fourth-quarter results. Moreover, the company expects robust sales this year as it should keep benefitting from 5G roll-outs. Given the company’s expanding market share, NOK might be worth buying for under $5. Read more...
: TSM |  News, Ratings, and Charts

3 Semiconductor Stocks to Invest in Right Now and 1 to Sell

Despite the major turbulence in the semiconductor industry, global sales reached the highest-ever annual total last year. Given the solid prospects of the industry, fundamentally strong semiconductor stocks Taiwan Semiconductor (TSM), Broadcom (AVGO), and United Microelectronics (UMC) might be worth buying. However, fundamentally weak NVIDIA (NVDA) might be best avoided. Keep reading...
: KO |  News, Ratings, and Charts

If You Could Only Own 3 Stocks, It Should Be These

Consumer sentiment has been buoyed by the recent cooldown in inflation and encouraging economic data. However, with interest rate hikes expected to continue, the risk of the economy tipping into a recession remains. Hence, fundamentally strong stocks Coca-Cola (KO), Merck & Co (MRK), and Valero Energy (VLO) that pay reliable dividends might be solid buys. Read on...
: FTNT |  News, Ratings, and Charts

The 3 Best Software Stocks Money Can Buy and 1 to Avoid

The software industry is expected to witness solid growth amid the growing market for advance technologies like the cloud and artificial intelligence. However, the Fed’s rate hikes might remain a significant headwind this year. While we think Fortinet (FTNT), Progress Software (PRGS), and YEXT (YEXT) might be worth buying, fundamentally weak software stock Coinbase Global (COIN) could be best avoided. Keep reading...
: CI |  News, Ratings, and Charts

4 Stocks You Can Rely on in Any Market Conditions

Rising bond yields and a strong dollar are dampening the stock market rally. Also, experts see a significant chance of inflation rebounding. Therefore, fundamentally strong stocks, Cigna (CI), McKesson (MCK), Pilgrim’s Pride (PPC), and Global Partners (GLP), which can potentially withstand any market conditions, could be ideal investments now. Read on...
: LMT |  News, Ratings, and Charts

Defense Stocks to Keep on Your Radar in February 2023

Rising geopolitical tension and increasing government spending on defense is expected to help the industry witness solid growth in the near term. So, fundamentally strong defense stocks Lockheed Martin (LMT), General Dynamics (GD), and Textron (TXT) might be worth keeping on your radar. Keep reading...
: MRK |  News, Ratings, and Charts

5 Top Stocks to Buy for 2023

The stock market witnessed a solid start this year amid improving investors’ optimism. Moreover, experts see increased chances of a soft landing. So, fundamentally strong stocks Merck (MRK), Novartis (NVS), Sysco (SYY), Progress Software (PRGS), and LSI Industries (LYTS) could be solid buys now. These stocks pay consistent dividends. Read more...
: AMGN |  News, Ratings, and Charts

5 Biotech Stocks That Could Make You Rich in 10 Years

The biotech industry is rapidly growing amid rising private and government investments and technological advancements. Given the solid prospects of the industry, fundamentally strong biotech stocks Amgen (AMGN), Vertex (VRTX), United Therapeutics (UTHR), Jazz Pharmaceuticals (JAZZ), and Exelixis (EXEL) might be ideal long-term investments for steady returns. Keep reading...
: WYNN |  News, Ratings, and Charts

If You Own These 3 Stocks, Sell Them Now

The strong labor market is expected to lead to continued rate hikes by the Fed, which might eventually lead to a recession. Therefore, fundamentally weak stocks Wynn Resorts (WYNN), Affirm Holdings (AFRM), and ForgeRock (FORG) might be best avoided now. Read more...
Page generated in 1.5284 seconds.